TipRanks The rise of GLP-1 weight-loss drugs has arguably been the second-hottest trend in the stock market right now — second to generative artificial intelligence (AI). Undoubtedly, the “GLP-1 run” has brought a great deal of enthusiasm to the biotechnology and healthcare scenes. However, I don’t expect it’ll be the last ground-breaking innovation from the … Read more
Key Points The Health Care Select Sector SPDR Fund has dropped 3.81% in the last month and 8.03% in the past three months. Pharmaceuticals’ weak earnings reports are contributing to the healthcare sector’s recent underperformance. Bristol Myers Squibb, AbbVie, Merck, Johnson & Johnson, and Pfizer all traded below previous highs due to earnings concerns. 5 … Read more
America’s Food Giants Confront the Ozempic Era The Wall Street Journal Source link credite
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit Card Debts The Wall Street Journal Source link